When compared to early and late invasive lung adenocarcinoma, studies have shown that AMs (defined as CD11c+ F4/80+ CD64+ Siglec-F+) are replaced by TAMs (CD11b+ F4/80+ CD64+ Siglec-F-) as cancer progresses (8). The gene discussed is FCGR1A; the disease is lung adenocarcinoma.